Filing Details
- Accession Number:
- 0001203311-17-000074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-08 19:32:53
- Reporting Period:
- 2017-09-06
- Accepted Time:
- 2017-09-08 19:32:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1633639 | S Darren Cline | 21823 30Th Drive Se Bothell WA 98021 | Evp, Commercial | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-06 | 5,024 | $16.41 | 77,230 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-09-06 | 5,024 | $15.46 | 82,254 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-06 | 5,024 | $51.94 | 77,230 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2017-09-06 | 5,024 | $0.00 | 5,024 | $16.41 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-09-06 | 5,024 | $0.00 | 5,024 | $15.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-10-29 | No | 4 | M | Direct | |
| 2,268 | 2021-08-24 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Shares vested at a rate of 25% on October 29, 2011 and monthly thereafter until all the shares are fully vested on October 29, 2014.
- Shares vested at a rate of 25% on August 24, 2012 and monthly thereafter until all the shares are fully vested on August 24, 2015.
Billionaire Hedge Funds
